Fig. 10
From: Prognostic value of circadian rhythm-associated genes in breast cancer
Development and validation of a nomogram. (a) Construction of a nomogram that integrates the identified predictive factors to estimate 1-, 3-, 5-, and 7-year survival probabilities for BC patients. (b) Calibration curve demonstrating the concordance between the nomogram-predicted survival probabilities and actual outcomes, indicating the accuracy of the model. (c) DCA evaluating the clinical utility of the nomogram by assessing the net benefit across different threshold probabilities